17 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 17 of 17 clinical reviews.
A guide to how methimazole affects appetite and food cravings in hyperthyroid patients, including the thyroid-metabolic axis, expected timelines, and when appetite changes signal a problem.
A physician-level review of methimazole's autoimmune mechanisms, drug-induced immune reactions, monitoring protocols, and clinical decision-making for patients with Graves disease and co-existing autoimmune conditions.
A guide to how methimazole affects bone mineral density, fracture risk, and skeletal outcomes in hyperthyroidism management, with primary-literature citations and practical monitoring guidance.
A clinician-level review of the evidence on methimazole and cancer risk, covering thyroid cancer signals, hematologic concerns, epidemiologic data, and what current guidelines recommend for patients on long-term antithyroid therapy.
A clinical review of how methimazole treats hyperthyroidism and what the evidence says about its effects on brain fog, memory, mood, and overall cognitive function in Graves disease and toxic thyroid states.
A comparison of compounded methimazole versus branded Tapazole covering bioavailability, cost, dosing, safety, and when each formulation is appropriate for hyperthyroidism and Graves disease management.
A full clinical review of methimazole-induced and hyperthyroidism-related hair and skin changes, including alopecia, urticaria, and vasculitis, with primary-literature citations and management guidance.
A guide to how methimazole affects liver function, covering hepatotoxicity risk, monitoring protocols, drug comparisons, and management of abnormal LFTs during hyperthyroidism treatment.
A clinician-level review of how methimazole affects anxiety, depression, cognition, and emotional regulation in hyperthyroid patients, with primary-literature citations and dosing guidance.
How methimazole restores thyroid-driven metabolic control, what happens to BMR, thermogenesis, and body weight during treatment, and what clinicians need to know about monitoring and dosing.
A physician-level guide to the methimazole pre-surgery hold window for hyperthyroidism and Graves disease: when to stop, when to restart, iodine loading, and how to avoid thyroid storm.
A clinical guide to the risk of hyperthyroidism returning after stopping methimazole: who is more likely to relapse, what the evidence actually supports, how tapering is typically approached, and when to escalate to definitive therapy.
Does methimazole protect the kidneys or harm them? A primary-literature analysis of methimazole's renal effects in hyperthyroidism and Graves disease, including GFR changes, ANCA-associated vasculitis risk, and dosing guidance.
A clinician-level review of how methimazole affects libido, erectile function, menstrual cycles, and fertility, with primary-literature citations, real doses, and practical management steps.
A clinical deep-dive into how methimazole treats hyperthyroidism and reshapes sleep architecture: what the evidence shows on slow-wave sleep, REM cycles, nocturnal awakenings, and what thyroid normalization means for your patients' nights.
A clinician-discussion guide to methimazole dosing across time zones, handling missed or delayed doses during travel, and knowing when a travel disruption needs a phone call rather than self-adjustment.
A week-by-week guide to methimazole (Tapazole) for hyperthyroidism and Graves disease. Learn what symptoms improve first, when labs shift, and which warning signs need same-day care.